OVERVIEW

Atopic Dermatitis Update: Practical Strategies, New Approaches Video Program is organized by Global Academy for Medical Education and will be held Jun 01, 2017 - Jun 30, 2019.

Target Audience:
This activity is intended for dermatologists, pediatricians, family practitioners, internists, nurses, nurse practitioners, physician assistants, and other clinicians who treat patients with atopic dermatitis (AD).

Designation Statements:
The University of Louisville Office of Continuing Medical Education & Professional Development designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Nursing Education: Postgraduate Institute for Medicine is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. This educational activity for 1.0 contact hour(s) is provided by the Postgraduate Institute for Medicine. Designated for 0.1 contact hours of pharmacotherapy credit for Advance Practice Registered Nurses.

Educational Needs:
Atopic dermatitis (AD) is a chronic, relapsing inflammatory skin disease that is associated with significant morbidity. Symptoms of AD, including erythema and pruritus, along with common comorbidities such as sleep and mood disturbances, can significantly affect the quality of life for patients and their families. Concern about potential adverse effects of steroids can mean that AD is often undertreated. As emerging science continues to reveal the underlying pathophysiology of AD, new steroid-sparing topical and systemic treatments are being developed to target the immunological mechanisms that produce characteristic AD symptoms. Clinicians need to be familiar with the safety and efficacy data relevant to the use of current and emerging therapies. Clinicians also need to be prepared to counsel families about comprehensive approach for managing AD and for preventing flares, including effective skin hygiene and proper application of adequate doses of topical preparations.

Learning Objectives:
By viewing and studying this activity, participants should be better able to:
• Discuss the immunodulatory pathways that contribute to atopic dermatitis (AD) symptomatology
• Design strategies for proactive management of AD
• Consider the safety and efficacy data for new and emerging agents when designing a course of therapy for atopic dermatitis
• Counsel patients about the role of food allergy in atopic dermatitis (AD) Address common AD comorbidities, including sleep and mood disturbances

Additional details will be posted as soon as they are available.